There are 4 papers on Ubiquinol-10 in aging research: 2 trials and 1 observational study in people, 1 in animals.
See all 7 papers on Ubiquinol-10
“Percent reductions of ubiquinol-10 and those of total cholesterol showed a positive correlation (r = 0.627, p = 0.0165).”
- Human trial2
- Humans1
- Animals1
Interventions
2Atorvastatin
downin humans1
1 study
Atorvastatin
downin humans1
Atorvastatin decreases Ubiquinol-10 in humans (from 0.81 +/- 0.21 to 0.46 +/- 0.10 microg/ml (p < 0.0001)).
“mean levels of serum ubiquinol-10 and ubiquinone-10 levels decreased significantly from 0.81 +/- 0.21 to 0.46 +/- 0.10 microg/ml (p < 0.0001)”
Human trial10 mg/day8 weeksn = 14
Journal of atherosclerosis and thrombosis
Smoking
downin humans1
1 study
Smoking
downin humans1
Smoking is linked with lower Ubiquinol-10 in humans (smokers vs non-smokers) (P = 0.006 or P = 0.009).
“plasma ubiquinol-10 was found to be reduced amongst smokers”
Humanssmokers vs non-smokersplasma
Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia
Atherosclerosis
Upstream
2Hypertension
downin humans1
1 study
Hypertension
downin humans1
Hypertension is linked with lower Ubiquinol-10 in humans (hyperlipidaemic patients with hypertension vs without).
“The hyperlipidaemic patients with hypertension had a lower proportion of ubiquinol-10 than subjects without.”
Humanshyperlipidaemic patients with hypertension vs withoutplasma
Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia
Atherosclerosis
Hyperlipidemia
downin humans1
1 study
Hyperlipidemia
downin humans1
Hyperlipidemia is linked with lower Ubiquinol-10 in humans (hyperlipidaemic patients vs healthy controls) (P = 0.001 and 0.008).
“Plasma ubiquinol-10, expressed as a percentage of total ubiquinol-10 + ubiquinone-10 or normalized to plasma lipids, was lower in the patients than in controls”
Humanshyperlipidaemic patients vs healthy controlsplasma
Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia
Atherosclerosis
Associations
2Total cholesterol
upin humans1
1 study
Total cholesterol
upin humans1
Ubiquinol-10 is associated with total cholesterol in humans (r = 0.627, p = 0.0165).
“Percent reductions of ubiquinol-10 and those of total cholesterol showed a positive correlation (r = 0.627, p = 0.0165).”
Human trial10 mg/day8 weeksn = 14
Journal of atherosclerosis and thrombosis
Triglyceride
downin humans1
1 study
Triglyceride
downin humans1
Triglyceride is associated with Ubiquinol-10 in humans.
“A negative correlation was found between the proportion of ubiquinol-10 and plasma triglycerides.”
Humansplasma
Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia
Atherosclerosis